Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
14.50
+0.63 (4.54%)
At close: Aug 13, 2026, 4:00 PM EDT
14.73
+0.23 (1.59%)
After-hours: Aug 13, 2026, 7:58 PM EDT
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $1.34 billion as of August 13, 2026. Its market cap has increased by 384.40% in one year.
Market Cap
1.34B
Enterprise Value
1.25B
1-Year Change
384.40%
Ranking
Category
Stock Price
$14.50
ChartMarket Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $1.34B, an increase of 285.62%. That is a compound annual growth rate of 28.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 1.34B | 217.21% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.36B |
| Immatics | 1.33B |
| Aktis Oncology | 1.33B |
| Vor Biopharma | 1.32B |
| Novavax | 1.31B |
| Seaport Therapeutics | 1.27B |
| Corvus Pharmaceuticals | 1.27B |
| Cullinan Therapeutics | 1.26B |